Ricardo Armisen, M.D./Ph.D.
Affiliations: | 2002- | Universidad de Chile, Santiago, Región Metropolitana, Chile | |
2019- | Clínica Alemana Universidad del Desarrollo |
Google:
"Ricardo Armisen"Mean distance: (not calculated yet)
Children
Sign in to add traineePablo Baez | grad student | Universidad de Chile | |
Yanara Bernales | grad student | Clínica Alemana Universidad del Desarrollo | |
Claudio Capelli | grad student | Universidad de Chile | |
Pamela Rojas de Santiago | grad student | Universidad Catolica de Chile | |
Valentina Garate | grad student | Universidad de Chile | |
Jalaj Jain | grad student | Universidad de Talca | |
Fernanda Morales | grad student | Universidad de Chile | |
Marcela Morales | grad student | Universidad de Chile | |
Eduardo Sagredo | grad student | Universidad de Chile | |
Alfredo Sagredo | grad student | Universidad de Chile | |
Cesar Echeverria | post-doc | Universidad de Chile | |
Rocio Retamales | post-doc | Clínica Alemana Universidad del Desarrollo | |
Solange Rivas | post-doc | Clínica Alemana Universidad del Desarrollo | |
Alejandro Blanco | research scientist | Clínica Alemana Universidad del Desarrollo | |
Evelin Gonzalez | research scientist | Clínica Alemana Universidad del Desarrollo | |
Gonzalo Sepulveda | research scientist | Clínica Alemana Universidad del Desarrollo |
Collaborators
Sign in to add collaboratorkatherine marcelain | collaborator | Universidad de Chile | |
Felipe Simon | collaborator | Universidad Andrés Bello |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bernal YA, Durán E, Solar I, et al. (2024) ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer. International Journal of Molecular Sciences. 25 |
Tapia-Valladares C, Valenzuela G, González E, et al. (2024) Distinct Driver Pathway Enrichments and a High Prevalence of Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis. International Journal of Molecular Sciences. 25 |
Bernal YA, Blanco A, Sagredo EA, et al. (2024) A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer. Biomedicines. 12 |
Rivas S, Marín A, Samtani S, et al. (2022) MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies. International Journal of Molecular Sciences. 23 |
Oróstica KY, Saez-Hidalgo J, de Santiago PR, et al. (2022) Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients. Journal of Translational Medicine. 20: 373 |
Morales F, Pérez P, Tapia JC, et al. (2022) Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells. Gene. 819: 146246 |
Torres M, Castillo K, Armisén R, et al. (2022) Correction: Prion Protein Misfolding Affects Calcium Homeostasis and Sensitizes Cells to Endoplasmic Reticulum Stress. Plos One. 17: e0262628 |
Salvo M, González-Feliú E, Toro J, et al. (2021) Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America. Journal of Personalized Medicine. 11 |
Cordova-Delgado M, Bravo ML, Cumsille E, et al. (2021) A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer. Bmc Cancer. 21: 1030 |
Rodriguez DA, Zamorano S, Lisbona F, et al. (2021) BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α. The Embo Journal. 40: e109146 |